Lv41
476 积分 2023-11-07 加入
Molecular Design and Preclinical Evaluation of GenSci143, a Novel B7-H3- and PSMA-Directed Bispecific Antibody-Drug Conjugate, for the Treatment of Prostate Cancer
4小时前
已完结
Integrative Surface Antigen Profiling of KLK2 and STEAP1 in Advanced Prostate Cancer
4小时前
已完结
Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates
1天前
已完结
Engineering N-glycosylation mutations in IL-12 enhances sustained cytotoxic T lymphocyte responses for DNA immunization
4天前
已完结
Biosynthesis and Posttranslational Regulation of Human IL-12
4天前
已完结
Humoral determinants of checkpoint immunotherapy
17天前
已完结
Porustobart (HBM4003) plus Toripalimab as Second-Line Therapy in Patients with Advanced Hepatocellular Carcinoma: A Multicenter, Open-Label, Phase I Study
28天前
已完结
Biomarker-directed, pembrolizumab-based combination therapy in non-small cell lung cancer: phase 2 KEYNOTE-495/KeyImPaCT trial interim results
29天前
已完结
Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy from a First-in-Human Study of Volrustomig, a Novel PD-1/CTLA-4 Bispecific Antibody
1个月前
已完结
Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial
1个月前
已完结
皖公网安备34019202002308
